Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M460Revenue $M0.8Net Margin (%)-3,710.9Z-Score13.0
Enterprise Value $M400EPS $-2.7Operating Margin %-3,509.6F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-3,710.9Higher ROA y-yN
Price/Book7.710-y EBITDA Growth Rate %0Quick Ratio13.0Cash flow > EarningsN
Price/Sales2975-y EBITDA Growth Rate %0Current Ratio13.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-65.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-2,190.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.4ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OCUL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Polaris Venture Management Co.10% Owner 2015-02-02Sell500,000$29.5-19.76 view
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$1382.08 view
Sawhney AmarpreetPresident and CEO, 10% Owner 2014-07-30Buy76,922$1382.08 view
CHV II, L.P.10% Owner 2014-07-30Buy153,846$1382.08 view
Ankerud EricSee Remarks 2014-07-30Buy1,000$1382.08 view

Press Releases about OCUL :

    Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Apr 29 2015
    Ocular Therapeutix (OCUL) in Focus: Stock Goes Down 6.4% - Tale of the Tape Apr 10 2015
    Ocular Therapeutix Slumps 19% after Negative Study Data - Analyst Blog Apr 08 2015
    What We’re Trading Apr 07 2015
    Early movers: JPM, FDX, INFA, VIAB, GM & more Apr 07 2015
    Clovis Cancer 'Breakthrough,' Oculus Flop Top Biotech News Late Apr 06 2015
    Ocular Therapeutix slumps on eye treatment study Apr 06 2015
    Ocular Therapeutix slumps on eye treatment study Apr 06 2015
    Biotech company Ocular Therapeutix is imploding after announcing disappointing trial results Apr 06 2015
    Ocular Therapeutix Eye-Pain Plug Flops Confirmatory Pivotal Trial Apr 06 2015
    Allegiant Travel Co Earnings Call scheduled for 5:00 pm ET today Apr 06 2015
    Ocular Therapeutix eye drug misses a main goal in second late-stage study Apr 06 2015
    Ocular Therapeutix™ Reports Topline Clinical Data for its Second Phase 3 Clinical Trial Evaluating... Apr 06 2015
    Ocular Therapeutix™ Reports Topline Clinical Data for its Second Phase 3 Clinical Trial Evaluating... Apr 06 2015
    OCULAR THERAPEUTIX, INC Financials Mar 26 2015
    OCULAR THERAPEUTIX, INC Files SEC form 10-K, Annual Report Mar 20 2015
    Ocular Therapeutix (OCUL) is in Overbought Territory: What's Next? - Tale of the Tape Mar 17 2015
    Ocular Therapeutix Eye-Pain Plug Benefits Still Unclear Mar 10 2015
    Ocular Therapeutix Inc Earnings Call scheduled for 8:00 am ET today Mar 10 2015
    Ocular Therapeutix reports 4Q loss Mar 10 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK